Clearance Summary
AVACEN 100 received FDA 510(k) clearance under submission number K133981, sponsored by Avacen, Inc.. The device was reviewed via the Abbreviated premarket notification pathway and assigned to the Physical Medicine review panel. The statutory decision date of record is 2014-08-15.
- Submission: K133981
- Applicant / Sponsor: Avacen, Inc.
- Clearance pathway: Abbreviated
- Review panel: Physical Medicine
- Device class: Class II
- Regulation citation: 21 CFR 890.5740
- Decision date: 2014-08-15
Classification & Regulation
This clearance is catalogued under FDA product code IRT and 21 CFR 890.5740, within the Physical Medicine review panel as a Class II device.